NEW DELHI : India is in negotiations with western vaccine makers in an effort to secure tens of millions of doses in the next few months, which would ease supply shortages that have been stymying the country’s massive immunization campaign, people familiar with the matter said.
The country is in talks to acquire 50 million doses of a vaccine produced by Pfizer Inc. and BioNTech SE, the people said. It is also expecting to receive about seven million doses of a vaccine made by Moderna Inc.
from the U.S. through Covax, a program to supply Covid-19 vaccines to poorer nations. Indian authorities are also in an advanced stage of negotiations with Johnson & Johnson, which has a deal with India-based Biological E.